Medical therapies for inflammatory bowel disease

被引:2
|
作者
Stotland, BR [1 ]
Cirigliano, MD [1 ]
Lichtenstein, GR [1 ]
机构
[1] Univ Penn, Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA
来源
HOSPITAL PRACTICE | 1998年 / 33卷 / 05期
关键词
D O I
10.1080/21548331.1998.11443696
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Inflammatory bowel disease is a spectrum of disorders whose etiology and pathogenesis are unclear. No therapy is standard; many modalities exist for management. New drugs, improved formulations of existing drugs, combination therapy, and biologic agents offer more effective relief and maintain disease remission.
引用
收藏
页码:141 / +
页数:13
相关论文
共 50 条
  • [1] Medical therapies for inflammatory bowel disease: An overview
    Lichtenstein, GR
    AUTOIMMUNE DISEASES IN PEDIATRIC GASTROENTEROLOGY, 2002, 127 : 124 - 144
  • [2] MEDICAL THERAPIES FOR INFLAMMATORY BOWEL-DISEASE
    LICHTENSTEIN, GR
    CURRENT OPINION IN GASTROENTEROLOGY, 1994, 10 (04) : 390 - 403
  • [3] MEDICAL THERAPIES FOR INFLAMMATORY BOWEL-DISEASE
    LICHTENSTEIN, GR
    CURRENT OPINION IN GASTROENTEROLOGY, 1993, 9 (04) : 588 - 599
  • [4] Optimizing Conventional Medical Therapies in Inflammatory Bowel Disease in 2014
    Asthana, Anil Kumar
    Sparrow, Miles P.
    Peyrin-Biroulet, Laurent
    CURRENT DRUG TARGETS, 2014, 15 (11) : 1002 - 1010
  • [5] Impact of medical therapies on inflammatory bowel disease complication rate
    Catherine Reenaers
    Jacques Belaiche
    Edouard Louis
    World Journal of Gastroenterology, 2012, (29) : 3823 - 3827
  • [6] Impact of medical therapies on inflammatory bowel disease complication rate
    Reenaers, Catherine
    Belaiche, Jacques
    Louis, Edouard
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (29) : 3823 - 3827
  • [7] IMMUNOMODULATORY AGENTS AND OTHER MEDICAL THERAPIES IN INFLAMMATORY BOWEL-DISEASE
    COHEN, RD
    HANAUER, SB
    CURRENT OPINION IN GASTROENTEROLOGY, 1995, 11 (04) : 321 - 330
  • [8] Phosphodiesterase inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease
    Keshavarzian, Ali
    Mutlu, Ece
    Guzman, Juan P.
    Forsyth, Christopher
    Banan, Ali
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (09) : 1489 - 1506
  • [9] Biologic therapies in inflammatory bowel disease
    Cohen, Lawrence B.
    Nanau, Radu M.
    Delzor, Faustine
    Neuman, Manuela G.
    TRANSLATIONAL RESEARCH, 2014, 163 (06) : 533 - 556
  • [10] Novel Therapies for Inflammatory Bowel Disease
    Shivali Berera
    Gary R. Lichtenstein
    Current Treatment Options in Gastroenterology, 2022, 20 (1) : 81 - 100